Articles in this database are automatically generated by our AI system based on data from the Digicomply APP. While we strive for accuracy, the articles may not contain complete or verified information and are intended for informational purposes only. For accurate and reliable information, we recommend using SGS Digicomply or consulting verified sources and experts. All content is copyrighted; please credit SGS Digicomply (digicomply.com) when sharing.
On July 15, 2025, the U.S. Food and Drug Administration reported the detection of 7-oh in specific chewable tablets. The affected product is identified as 7 oh chewable tablets white vein advanced alkaloids lemon. This incident falls under the category of "Other incident" and originates from the United States of America.
The identification of 7-oh raises concerns regarding the safety and quality of the product. The presence of this compound has prompted regulatory scrutiny, leading to further investigation by authorities.
Consumers are advised to remain informed about product safety alerts and to consult relevant sources for updates regarding this incident. The U.S. Food and Drug Administration continues to monitor the situation and provide guidance as necessary.
- Incident: 7-oh has been detected in 7 oh chewable tablets white vein advanced alkaloids lemon .
- Date: 2025-07-15
- Product: 7 oh chewable tablets white vein advanced alkaloids lemon
- Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Origin of issue: United States of America
- Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Incident Category: Other incident
- Hazard Category: null
- Source: U.S. Food and Drug Administration
For more detailed information about this and other similar incidents, with access to filtering options, historical data, and trend analysis, try the SGS Digicomply Food Safety Software.
Explore SGS Digicomply Food Safety Intelligence Hub demos here. (for enterprises only, no individual plans)
